- Home
- ONON vs ICLR Comparison
ONON vs ICLR Comparison
Compare ONON & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONON
- ICLR
- Stock Information
- Founded
- ONON 2010
- ICLR 1990
- Country
- ONON Switzerland
- ICLR Ireland
- Employees
- ONON N/A
- ICLR N/A
- Industry
- ONON Shoe Manufacturing
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- ONON Consumer Discretionary
- ICLR Health Care
- Exchange
- ONON Nasdaq
- ICLR Nasdaq
- Market Cap
- ONON 19.5B
- ICLR 16.4B
- IPO Year
- ONON 2021
- ICLR 1998
- Fundamental
- Price
- ONON $48.43
- ICLR $201.39
- Analyst Decision
- ONON Buy
- ICLR Strong Buy
- Analyst Count
- ONON 25
- ICLR 12
- Target Price
- ONON $57.04
- ICLR $278.27
- AVG Volume (30 Days)
- ONON 4.3M
- ICLR 913.3K
- Earning Date
- ONON 03-04-2025
- ICLR 02-19-2025
- Dividend Yield
- ONON N/A
- ICLR N/A
- EPS Growth
- ONON 55.69
- ICLR 28.78
- EPS
- ONON 0.46
- ICLR 9.53
- Revenue
- ONON $2,555,669,993.00
- ICLR $8,281,675,999.00
- Revenue This Year
- ONON $31.74
- ICLR $4.00
- Revenue Next Year
- ONON $27.95
- ICLR $1.37
- P/E Ratio
- ONON $106.05
- ICLR $21.18
- Revenue Growth
- ONON 26.12
- ICLR 1.99
- 52 Week Low
- ONON $27.37
- ICLR $181.51
- 52 Week High
- ONON $64.05
- ICLR $347.72
- Technical
- Relative Strength Index (RSI)
- ONON 28.84
- ICLR 54.92
- Support Level
- ONON $50.61
- ICLR $181.51
- Resistance Level
- ONON $53.57
- ICLR $203.26
- Average True Range (ATR)
- ONON 2.51
- ICLR 6.32
- MACD
- ONON -0.98
- ICLR 1.50
- Stochastic Oscillator
- ONON 4.41
- ICLR 72.45
About ONON On Holding AG
On Holding AG is a premium performance sports brand rooted in technology, design, and impact. Its shoes, apparel, and accessories products are designed predominantly for athletic use, casual, or leisure purposes. It does not manufacture the products or the raw materials and relies instead on third-party suppliers and contract manufacturers. Geographically, it derives a majority of its revenue from the Americas and rest from Europe, Middle East and Africa, and Asia-Pacific region.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.